These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16044315)

  • 21. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
    Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
    J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bernard-Soulier syndrome: an update.
    Andrews RK; Berndt MC
    Semin Thromb Hemost; 2013 Sep; 39(6):656-62. PubMed ID: 23929303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment.
    Barnes C; Blanchette V; Canning P; Carcao M
    Transfus Med; 2005 Apr; 15(2):145-50. PubMed ID: 15859982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Obstetric and gynecological intervention in women with Bernard-Soulier syndrome: report of two cases].
    Mitrović M; Elezović I; Miljić P; Antić D
    Srp Arh Celok Lek; 2014; 142(5-6):351-5. PubMed ID: 25033594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bernard-Soulier syndrome in pregnancy with retinal detachment: a rare phenomenon.
    Igbokwe N; Benson G; Waireri J
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36129357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients.
    Aldouri M
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():41-6. PubMed ID: 12214147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overall experience with NovoSeven.
    Négrier C; Lienhart A
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S19-24. PubMed ID: 10850559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia.
    Balci YI; Karabulut A; Kabukcu S; Sari I; Keskin A
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):320-2. PubMed ID: 20460355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults.
    Grainger JD; Thachil J; Will AM
    Br J Haematol; 2018 Sep; 182(5):621-632. PubMed ID: 30117143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors.
    Mauser-Bunschoten EP; Koopman MM; Goede-Bolder AD; Leebeek FW; van der Meer J; van Marwijk Kooij GM; van der Linden PW;
    Haemophilia; 2002 Sep; 8(5):649-56. PubMed ID: 12199674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders.
    Birschmann I; Klamroth R; Eichler H; Schenk J; Kirchmaier CM; Halimeh S
    Haemophilia; 2013 Sep; 19(5):679-85. PubMed ID: 23647644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
    Javed A; Ayyub M; Abrar S; Mansoor M; Khan B; Hussain T
    J Ayub Med Coll Abbottabad; 2009; 21(2):171-3. PubMed ID: 20524499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bernard-Soulier syndrome (BSS) with uncontrollable menorrhagia.
    Bhadra D; Chakraborty S
    Asian J Transfus Sci; 2020; 14(1):93-95. PubMed ID: 33162718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of recombinant activated factor VII to control bleeding in a young child with qualitative platelet disorder: a case report.
    Inagaki M; Mori T; Tsunematsu Y; Ambo H; Kawai Y
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):317-22. PubMed ID: 16651876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant factor VIIa (NovoSeven) as a hemostatic agent.
    Hedner U
    Dis Mon; 2003 Jan; 49(1):39-48. PubMed ID: 12525827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors.
    Schneiderman J; Nugent DJ; Young G
    Haemophilia; 2004 Jul; 10(4):347-51. PubMed ID: 15230948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic characterization of patients with Bernard-Soulier syndrome and their relatives from Southern Iran.
    Afrasiabi A; Lecchi A; Artoni A; Karimi M; Ashouri E; Peyvandi F; Mannucci PM
    Platelets; 2007 Sep; 18(6):409-13. PubMed ID: 17763149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A variant form of Bernard-Soulier syndrome: mild haemostatic defect associated with partial platelet GPIb deficiency.
    Stevens MC; Blanchette VS; Freedman MH; Sparling C; Kunicki TJ
    Clin Lab Haematol; 1988; 10(4):443-51. PubMed ID: 2855048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia.
    Kadowaki S; Makino S; Mohri Y; Awaguni H; Shinozuka J; Imashuku S
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):155-158. PubMed ID: 33196513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I study.
    Macik BG; Lindley CM; Lusher J; Sawyer WT; Bloom AL; Harrison JF; Baird-Cox K; Birch K; Glazer S; Roberts HR
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):521-7. PubMed ID: 8218848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.